首页|Tumor biomarkers for diagnosis,prognosis and targeted therapy
Tumor biomarkers for diagnosis,prognosis and targeted therapy
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
Tumor biomarkers,the substances which are produced by tumors or the body's responses to tumors during tumorigenesis and progression,have been demonstrated to possess critical and encouraging value in screening and early diagnosis,prognosis prediction,recurrence detection,and therapeutic efficacy monitoring of cancers.Over the past decades,continuous progress has been made in exploring and discovering novel,sensitive,specific,and accurate tumor biomarkers,which has significantly promoted personalized medicine and improved the outcomes of cancer patients,especially advances in molecular biology technologies developed for the detection of tumor biomarkers.Herein,we summarize the discovery and development of tumor biomarkers,including the history of tumor biomarkers,the conventional and innovative technologies used for biomarker discovery and detection,the classification of tumor biomarkers based on tissue origins,and the application of tumor biomarkers in clinical cancer management.in particular,we highlight the recent advancements in biomarker-based anticancer-targeted therapies which are emerging as breakthroughs and promising cancer therapeutic strategies.We also discuss limitations and challenges that need to be addressed and provide insights and perspectives to turn challenges into opportunities in this field.Collectively,the discovery and application of multiple tumor biomarkers emphasized in this review may provide guidance on improved precision medicine,broaden horizons in future research directions,and expedite the clinical classification of cancer patients according to their molecular biomarkers rather than organs of origin.
Department of Biotherapy,Cancer Center and State Key Laboratory of Biotherapy,West China Hospital,Sichuan University,Chengdu 610041,China
West China School of Pharmacy,Sichuan University,Chengdu 610041,China
School of Medicine,Tibet University,Lhasa 850000,China
National Chengdu Center for Safety Evaluation of Drugs,State Key Laboratory of Biotherapy,West China Hospital,Sichuan University,Chengdu 610041,China
展开 >
135 Project for Disciplines of Excellence of West China Hospital Sichuan UniversityNational Natural Sciences Foundation of ChinaNatural Sciences Foundation of Sichuan
NETL
NSTL
万方数据
